Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OV21: IP vs IV Chemotherapy in Ovarian Cancer
NCT00993655Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Mar 2010
- Primary completion
- Mar 2016
- Modality
- Nanoparticles, DNA Intercalators/Alkylators, Cytokines & Interferons
- Countries
- 4
01
Overview
A Phase 2 trial of carboplatin, Paclitaxel Micelles for Injection, Cisplatin micelle injection (HA132) in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Canadian Cancer Trials Group. Started Mar 2010; status: completed.
02
Drugs
carboplatinPaclitaxel Micelles for InjectionCisplatin micelle injection (HA132)
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00993655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993655.